Literature DB >> 28855311

A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.

Taylor B Poston1, Yanyan Qu2, Jenna Girardi1, Catherine M O'Connell1, Lauren C Frazer1, Ali N Russell1, McKensie Wall1, Uma M Nagarajan1, Toni Darville3.   

Abstract

Chlamydia is responsible for millions of new infections annually, and current efforts focus on understanding cellular immunity for targeted vaccine development. The Chlamydia-specific CD4 T cell response is characterized by the production of IFN-γ, and polyfunctional Th1 responses are associated with enhanced protection. A major limitation in studying these responses is the paucity of tools available for detection, quantification, and characterization of polyfunctional Ag-specific T cells. We addressed this problem by developing a TCR-transgenic (Tg) mouse with CD4 T cells that respond to a common Ag in Chlamydia muridarum and Chlamydia trachomatis Using an adoptive-transfer approach, we show that naive Tg CD4 T cells become activated, proliferate, migrate to the infected tissue, and acquire a polyfunctional Th1 phenotype in infected mice. Polyfunctional Tg Th1 effectors demonstrated enhanced IFN-γ production compared with polyclonal cells, protected immune-deficient mice against lethality, mediated bacterial clearance, and orchestrated an anamnestic response. Adoptive transfer of Chlamydia-specific CD4 TCR-Tg T cells with polyfunctional capacity offers a powerful approach for analysis of protective effector and memory responses against chlamydial infection and demonstrates that an effective monoclonal CD4 T cell response may successfully guide subunit vaccination strategies.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28855311      PMCID: PMC5770186          DOI: 10.4049/jimmunol.1700914

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  83 in total

1.  MyD88 deficiency leads to decreased NK cell gamma interferon production and T cell recruitment during Chlamydia muridarum genital tract infection, but a predominant Th1 response and enhanced monocytic inflammation are associated with infection resolution.

Authors:  Uma M Nagarajan; James Sikes; Daniel Prantner; Charles W Andrews; Lauren Frazer; Anna Goodwin; Jessica N Snowden; Toni Darville
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.

Authors:  Rolf Billeskov; Yichuan Wang; Shahram Solaymani-Mohammadi; Blake Frey; Shweta Kulkarni; Peter Andersen; Else Marie Agger; Yongjun Sui; Jay A Berzofsky
Journal:  J Immunol       Date:  2017-03-27       Impact factor: 5.422

3.  A TCR transgenic mouse reactive with multiple systemic dimorphic fungi.

Authors:  Marcel Wüthrich; Chiung Yu Hung; Ben H Gern; John C Pick-Jacobs; Kevin J Galles; Hanna I Filutowicz; Garry T Cole; Bruce S Klein
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

Review 4.  Immunological memory and protective immunity: understanding their relation.

Authors:  R Ahmed; D Gray
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

5.  Limited model antigen expression by transgenic fungi induces disparate fates during differentiation of adoptively transferred T cell receptor transgenic CD4+ T cells: robust activation and proliferation with weak effector function during recall.

Authors:  Marcel Wüthrich; Karen Ersland; John C Pick-Jacobs; Benjamin H Gern; Christopher A Frye; Thomas D Sullivan; Meghan B Brennan; Hanna I Filutowicz; Kevin O'Brien; Keegan D Korthauer; Stacey Schultz-Cherry; Bruce S Klein
Journal:  Infect Immun       Date:  2011-11-28       Impact factor: 3.441

6.  Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.

Authors:  Hong Yu; Karuna P Karunakaran; Xiaozhou Jiang; Robert C Brunham
Journal:  Vaccine       Date:  2014-06-30       Impact factor: 3.641

Review 7.  Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Authors:  Wei Liao; Jian-Xin Lin; Warren J Leonard
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

Review 8.  Diversity in T cell memory: an embarrassment of riches.

Authors:  Stephen C Jameson; David Masopust
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

9.  A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant.

Authors:  Janina Jiang; Guangchao Liu; Valerie A Kickhoefer; Leonard H Rome; Lin-Xi Li; Stephen J McSorley; Kathleen A Kelly
Journal:  Vaccines (Basel)       Date:  2017-01-19

10.  Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.

Authors:  Jorge R Almeida; David A Price; Laura Papagno; Zaïna Aït Arkoub; Delphine Sauce; Ethan Bornstein; Tedi E Asher; Assia Samri; Aurélie Schnuriger; Ioannis Theodorou; Dominique Costagliola; Christine Rouzioux; Henri Agut; Anne-Geneviève Marcelin; Daniel Douek; Brigitte Autran; Victor Appay
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  12 in total

1.  Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge.

Authors:  Nina Dieu Nhien Tran Nguyen; Anja W Olsen; Emma Lorenzen; Peter Andersen; Malene Hvid; Frank Follmann; Jes Dietrich
Journal:  NPJ Vaccines       Date:  2020-01-23       Impact factor: 7.344

2.  Early Colonization of the Upper Genital Tract by Chlamydia muridarum Is Associated with Enhanced Inflammation Later in Infection.

Authors:  Jennifer D Helble; Nicole V Reinhold-Larsson; Michael N Starnbach
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

Review 3.  Chlamydia Spreading from the Genital Tract to the Gastrointestinal Tract - A Two-Hit Hypothesis.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2017-12-27       Impact factor: 17.079

4.  T Cell-Independent Gamma Interferon and B Cells Cooperate To Prevent Mortality Associated with Disseminated Chlamydia muridarum Genital Tract Infection.

Authors:  Taylor B Poston; Catherine M O'Connell; Jenna Girardi; Jeanne E Sullivan; Uma M Nagarajan; Anthony Marinov; Amy M Scurlock; Toni Darville
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

Review 5.  Diversity in the T cell response to Chlamydia-sum are better than one.

Authors:  Jasmine C Labuda; Stephen J McSorley
Journal:  Immunol Lett       Date:  2018-09-01       Impact factor: 3.685

6.  A Chlamydia trachomatis Strain Expressing Ovalbumin Stimulates an Antigen-Specific CD4+ T Cell Response in Mice.

Authors:  Jennifer D Helble; Michael N Starnbach
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

7.  Innate IFN-γ Is Essential for Systemic Chlamydia muridarum Control in Mice, While CD4 T Cell-Dependent IFN-γ Production Is Highly Redundant in the Female Reproductive Tract.

Authors:  Miguel A B Mercado; Wuying Du; Priyangi A Malaviarachchi; Jessica I Gann; Lin-Xi Li
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

8.  IL-10 Producing B Cells Dampen Protective T Cell Response and Allow Chlamydia muridarum Infection of the Male Genital Tract.

Authors:  Leonardo R Sanchez; Gloria J Godoy; Melisa Gorosito Serrán; Maria L Breser; Facundo Fiocca Vernengo; Pablo Engel; Ruben D Motrich; Adriana Gruppi; Virginia E Rivero
Journal:  Front Immunol       Date:  2019-03-01       Impact factor: 7.561

Review 9.  T cell responses to Chlamydia.

Authors:  Jennifer D Helble; Michael N Starnbach
Journal:  Pathog Dis       Date:  2021-03-31       Impact factor: 3.166

10.  Gamma Interferon Is Required for Chlamydia Clearance but Is Dispensable for T Cell Homing to the Genital Tract.

Authors:  Jennifer D Helble; Rodrigo J Gonzalez; Ulrich H von Andrian; Michael N Starnbach
Journal:  mBio       Date:  2020-03-17       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.